-
Dr. Reddy’s launches generic Accolate
HYDERABAD, India Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug for the U.S. market, the company said.
Dr. Reddy’s announced the launch of zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a version of AstraZeneca’s Accolate, which had sales of $50 million during the 12-month period ended in August, according to IMS Health.
-
Study finds healthcare team could improve Type 2 diabetics' health
NEW YORK — Adding pharmacists to a primary care team could help diabetics better manage associated risks, according to a new study conducted by researchers from the University of Alberta.
Among 153 hypertensive Type 2 diabetes patients studied, 82 who had advice from a pharmacist were more likely to reach blood pressure treatment targets recommended by the Canadian Diabetes Association.